Literature DB >> 15695701

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

L A Arroyo1, A García-Curiel, M E Pachón-Ibañez, A C Llanos, M Ruiz, J Pachón, J Aznar.   

Abstract

We compared the E-test to the broth microdilution method for testing the susceptibility of 115 clinical isolates of Acinetobacter baumannii to colistin. Twenty-two (19.1%) strains were resistant to colistin and 93 (80.8%) strains were susceptible according to the reference broth microdilution method. A categorical agreement of 98.2% was found, with only two (1.7%) very major errors. Agreement within 1 twofold dilution between the E-test and the broth microdilution was 16.5%. Complete agreement was found for the strains for which MICs fell within the range of 0.25 to 1 microg of colistin/ml. However, there was poor concordance, particularly in extreme dilutions with higher MICs by the E-test method.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15695701      PMCID： PMC548043          DOI： 10.1128/JCM.43.2.903-905.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Authors:  M E Evans; D J Feola; R P Rapp
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

2.  Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.

Authors:  P Fernandez-Viladrich; X Corbella; L Corral; F Tubau; A Mateu
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

3.  Intrathecal use of colistin.

Authors:  W Vasen; P Desmery; S Ilutovich; A Di Martino
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

Authors:  M E Jiménez-Mejías; C Pichardo-Guerrero; F J Márquez-Rivas; D Martín-Lozano; T Prados; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-03-19       Impact factor: 3.267

5.  Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.

Authors:  C Urban; N Mariano; J J Rahal; E Tay; C Ponio; T Koprivnjak; J Weiss
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

6.  Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  A S Levin; A A Barone; J Penço; M V Santos; I S Marinho; E A Arruda; E I Manrique; S F Costa
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

7.  A reassessment of the in-vitro activity of colistin sulphomethate sodium.

Authors:  C R Catchpole; J M Andrews; N Brenwald; R Wise
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

8.  In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak.

Authors:  M D Appleman; H Belzberg; D M Citron; P N Heseltine; A E Yellin; J Murray; T V Berne
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam.

Authors:  E S Go; C Urban; J Burns; B Kreiswirth; W Eisner; N Mariano; K Mosinka-Snipas; J J Rahal
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

10.  Polymyxin-resistant Acinetobacter spp. isolates: what is next?

Authors:  Adriana O Reis; Deise A M Luz; Maria C B Tognim; Hélio S Sader; Ana C Gales
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more
  32 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  "All-in-one-plate" E-test and disk diffusion susceptibility co-testing for multiresistant Acinetobacter baumannii.

Authors:  J Gilad; M Giladi; F Poch; Y Aharoni; D Schwartz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

Review 3.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

4.  In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.

Authors:  Luis A Arroyo; Ingeborg Mateos; Verónica González; Javier Aznar
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

Review 5.  Polymyxins revisited.

Authors:  David Landman; Claudiu Georgescu; Don Antonio Martin; John Quale
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.

Authors:  Ellen S Moland; David W Craft; Seong-geun Hong; Soo-young Kim; Lucas Hachmeister; Shimon D Sayed; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

Review 7.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

8.  Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates.

Authors:  Wen-Chien Ko; Nan-Yao Lee; Siou Cing Su; Lenie Dijkshoorn; Mario Vaneechoutte; Li-Rong Wang; Jin-Jou Yan; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

9.  Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital.

Authors:  Seung Yeob Lee; Jong Hee Shin; Kyungwon Lee; Min Young Joo; Kyung Hwa Park; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang; Soo Hyun Kim
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

10.  High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii bacteremia: implication for pathogenesis and evaluation of therapy.

Authors:  Yu-Chung Chuang; Shan-Chwen Chang; Wei-Kung Wang
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.